PDS Biotechnology Corp Updates Corporate Presentation (Sept 2026)

What Happened On September 21, 2026, PDS Biotechnology Corp (PDSB) filed a Form 8-K under Item 8.01 to announce an updated corporate presentation deck. The presentation (titled "Corporate Presentation (September 2026)") is filed as Exhibit 99.1 and is incorporated by reference into the filing. The 8-K includes the exhibit and the Inline XBRL cover page (Exhibit 104); it does not report earnings, executive changes, or other material events in this filing.

Key Details

• Filing date: September 21, 2026 (Form 8-K, Item 8.01).
• Exhibit 99.1: Corporate Presentation (September 2026) was filed and incorporated by reference.
• Exhibit 104: Cover Page Interactive Data File (Inline XBRL) included.
• The filing does not include Item 2.02 (earnings) or Item 5.02 (executive changes).

Why It Matters An updated corporate presentation is an official source of the company’s current messaging on strategy, product pipeline, milestones, and financial highlights. Investors should review Exhibit 99.1 (available on the SEC EDGAR site or PDSB’s investor relations page) to see if the deck contains updated metrics, timelines, or disclosures that could affect the company’s outlook or upcoming catalysts. This 8-K itself does not announce revenue, quarterly results, or management changes.